MAX reported mixed Q3 results with a slightly increased top-line, but a lower than expected EBITDA margin. Despite a soft order intake, order backlog remains on a healthy level to reach the FY´23 guidance.
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
MAX reported mixed Q3 results with a slightly increased top-line, but a lower than expected EBITDA margin. Despite a soft order intake, order backlog remains on a healthy level to reach the FY´23 guidance.
